The Pharmacy Times® 503B Compounding Pharmacy Resource Center is a comprehensive resource for clinical news and expert insights on issues related to compounding pharmacies and drug safety.
January 16th 2024
Although robotics can be instrumental in assuring sterility and reducing the overall number of potential hazardous drug exposure events, certain tasks require vigilant oversight.
USP <800> Will Become Enforceable for Facilities Once Revisions of <795>, <797> Approved
July 25th 2022Kevin Straughn, PharmD, clinical pharmacist at Duke Regional Hospital, said once the 2 compounding chapters, <797> and <795> become enforceable, there will be a 6-month grace period before USP <800> becomes enforceable.
Read More
Opinion: The FDA is in a Hole With MOU on Compounding Medications—It Should Stop Digging
June 21st 2022Congress expected the FDA to draft a memorandum of understanding on interstate distributions of compounded medications that states would be willing to sign, but that’s not what the agency did.
Read More
Pharmacists Play Role in Pharmacogenomics Clinical Services
They should consider many factors and use clear guidance on predicting phenotypes from genotypes to intervene optimally based on specific drug-gene interactions.
Read More
Nicole Palmer, senior manager of Volunteer Engagement at US Pharmacopeia (USP), and Michelle Then, PharmD, MBA, member of the USP Healthcare Safety and Quality Expert Committee, discuss the benefits of being a volunteer at USP and the opportunities for students and early career pharmacists.
Watch
Expert: USP Medicine Supply Map Can Help Pharmacists Assess the Risk in Their Medicine Supply Chains
March 31st 2022Vimala Raghavendran, MBA, head of the Pharmaceutical Supply Chain Center at US Pharmacopeia (USP), explains how pharmacists can get involved in USP’s Medicine Supply Vulnerability Insights Series assessing global pharmaceutical supply chain vulnerabilities.
Watch
USP Requests Feedback From Pharmacists to Advance mRNA Quality Guidelines
February 25th 2022Diane McCarthy, director of biologics pipeline development at US Pharmacopeia (USP), discusses USP’s development of mRNA quality guidelines to help companies and regulators bring innovative medicines to market faster.
Watch
USP Survey Shows 9 Out of 10 Physicians Feel Their Trust in Medicine Supply Chain Has Eroded
February 11th 2022Ronald T. Piervincenzi, CEO of US Pharmacopeia (USP), discusses recent survey data demonstrating 90% of physicians had experienced an erosion of trust in the US supply chain’s ability to deliver safe, quality medicines.
Watch
Expert: Pharmacists, USP Worked Together ‘A Hundred Times Faster Than Ever Before’ in 2021
December 22nd 2021Ronald T. Piervincenzi, PhD, CEO of US Pharmacopeia, explains how pharmacists and USP came together in 2021 to work harder than ever before, as well as what can be done now to prepare for the next health crisis.
Watch
Expert: USP, Pharmacy Came Together in 2021 to Create Vaccine Toolkits ‘For Every Vaccine Created’
December 20th 2021Ronald T. Piervincenzi, PhD, CEO of US Pharmacopeia, discusses what stands out as the biggest challenge from the past year and what role USP and pharmacists had in overcoming that challenge.
Watch